Role of novel histone modifications in cancer

• Main Authors: Shanmugam, M.K, Arfuso, F, Arumugam, S, Chinnathambi, A, Jinsong, B, Warrier, S, Wang, L.Z, Kumar, A.P, Ahn, K.S, Sethi, G, Lakshmanan, M
• Other Authors: PHARMACOLOGY
• Format: Review
• Published: 2020
• Subjects: CCAAT enhancer binding protein; DNA (cytosine 5) methyltransferase 1; heterochromatin protein 1; heterochromatin protein 1alpha; histone H2A; histone H2AX; histone H2B; histone H3; NEDD8 protein; nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase 1; protein kinase C beta; SUMO 1 protein; ubiquitin protein ligase E3; unclassified drug; carcinogenesis; DNA binding; DNA methylation; epigenetics; excision repair; gene expression regulation; gene mutation; histone acetylation; histone modification; histone phosphorylation; histone ubiquitination; human; neddylation; oncogene; oncogene c myc; poly(adenosine diphosphate) ribosylation; protein glycosylation; Review; sumoylation; transcription regulation; tumor microenvironment; tumor suppressor gene; upregulation
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/173752
• Institution: National University of Singapore

10.18632/oncotarget.23356